Arbutus Biopharma (ABUS) Operating Margin (2013 - 2026)
Arbutus Biopharma (ABUS) reported Operating Margin of -588.17% for Q2 2026, down 602.02 percentage points from 13.86% a year earlier and down 682.46 percentage points from the prior quarter.
Powered by 
Analysis
Arbutus Biopharma (ABUS) Operating Margin (2013 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Arbutus Biopharma's Operating Margin came in at 81.99%, up 468.50 percentage points year-over-year; for FY2025, it came in at -270.96%, up 965.77 percentage points from FY2024.
- Operating Margin has a five-year change of +565.11 percentage points (FY2020 to FY2025).
- By year, Operating Margin came in at -1236.74% in FY2024 (-806.20 pp), -430.53% in FY2023 (-262.78 pp), -167.75% in FY2022 (+501.36 pp) and -669.11% in FY2021 (+166.96 pp).
- Five-year quarterly Operating Margin spans a low of -1636.86% in Q3 2025 and a high of 94.30% in Q1 2026.
- Year over year, Operating Margin gained in four of the last eight quarters, with an average year-over-year change of +163.79 percentage points.
- The high point for year-over-year Operating Margin in five years was Q1 2026 (a gain of 1551.16 percentage points); the low point was Q3 2024 (a drop of 1138.38 percentage points).
- Per Business Quant data, the three quarters before Q2 2026 came in at 94.30% (Q1 2026), -503.33% (Q4 2025) and -1636.86% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Operating Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 28.21% |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 37.86% |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | -3.52% |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 32.97% |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 20.57% |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 34.95% |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | -133.21% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 28.37% |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 37.40% |
| 10 | Arbutus Biopharma | 960.50 Mn | 587.48 Mn | - | -588.17% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -588.17% |
| Mar 31, 2026 | 94.30% |
| Dec 31, 2025 | -503.33% |
| Sep 30, 2025 | -1,636.86% |
| Jun 30, 2025 | 13.86% |
| Mar 31, 2025 | -1,456.86% |
| Dec 31, 2024 | -885.20% |
| Sep 30, 2024 | -1,601.19% |
| Jun 30, 2024 | -1,250.46% |
| Mar 31, 2024 | -1,263.90% |
| Dec 31, 2023 | -967.23% |
| Sep 30, 2023 | -462.82% |
| Jun 30, 2023 | -395.29% |
| Mar 31, 2023 | -260.40% |
| Dec 31, 2022 | -361.28% |
| Sep 30, 2022 | -299.24% |
| Jun 30, 2022 | -99.07% |
| Mar 31, 2022 | -87.23% |
| Dec 31, 2021 | -648.66% |
| Sep 30, 2021 | -551.14% |
API Access
Arbutus Biopharma Operating Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=operating-margin&ticker=ABUS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "operating-margin", "ticker": "ABUS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=operating-margin&ticker=ABUS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();